McKinsey July 29, 2021
We mapped out 1,382 biotechs based in Europe and some interesting themes emerged.
European biotechs have established a position of strength from which to enter the industry’s next act. Over the past three years, Europe’s biotech industry has made meaningful progress on attracting capital and bringing products to market.
Europe’s complex biotech landscape comprises hundreds of companies, dozens of countries, and multiple paths to innovation and financing. We mapped out 1,382 biotechs based in Europe and nine clusters emerged. As in previous years, service providers remain the largest cluster, with 29 percent of the European landscape.
While innovation is strong, it varies by country. France, Germany, and the United Kingdom (home to the largest biotech hub) stand out as the...
Today's Sponsors
Today's Sponsor